Home Upload Photo Upload Videos Write a Blog Analytics Messaging Streaming Create Adverts Creators Program
Bebuzee Afghanistan Bebuzee Albania Bebuzee Algeria Bebuzee Andorra Bebuzee Angola Bebuzee Antigua and Barbuda Bebuzee Argentina Bebuzee Armenia Bebuzee Australia Bebuzee Austria Bebuzee Azerbaijan Bebuzee Bahamas Bebuzee Bahrain Bebuzee Bangladesh Bebuzee Barbados Bebuzee Belarus Bebuzee Belgium Bebuzee Belize Bebuzee Benin Bebuzee Bhutan Bebuzee Bolivia Bebuzee Bosnia and Herzegovina Bebuzee Botswana Bebuzee Brazil Bebuzee Brunei Bebuzee Bulgaria Bebuzee Burkina Faso Bebuzee Burundi Bebuzee Cabo Verde Bebuzee Cambodia Bebuzee Cameroon Bebuzee Canada Bebuzee Central African Republic Bebuzee Chad Bebuzee Chile Bebuzee China Bebuzee Colombia Bebuzee Comoros Bebuzee Costa Rica Bebuzee Côte d'Ivoire Bebuzee Croatia Bebuzee Cuba Bebuzee Cyprus Bebuzee Czech Republic Bebuzee Democratic Republic of the Congo Bebuzee Denmark Bebuzee Djibouti Bebuzee Dominica Bebuzee Dominican Republic Bebuzee Ecuador Bebuzee Egypt Bebuzee El Salvador Bebuzee Equatorial Guinea Bebuzee Eritrea Bebuzee Estonia Bebuzee Eswatini Bebuzee Ethiopia Bebuzee Fiji Bebuzee Finland Bebuzee France Bebuzee Gabon Bebuzee Gambia Bebuzee Georgia Bebuzee Germany Bebuzee Ghana Bebuzee Greece Bebuzee Grenada Bebuzee Guatemala Bebuzee Guinea Bebuzee Guinea-Bissau Bebuzee Guyana Bebuzee Haiti Bebuzee Honduras Bebuzee Hong Kong Bebuzee Hungary Bebuzee Iceland Bebuzee India Bebuzee Indonesia Bebuzee Iran Bebuzee Iraq Bebuzee Ireland Bebuzee Israel Bebuzee Italy Bebuzee Jamaica Bebuzee Japan Bebuzee Jordan Bebuzee Kazakhstan Bebuzee Kenya Bebuzee Kiribati Bebuzee Kuwait Bebuzee Kyrgyzstan Bebuzee Laos Bebuzee Latvia Bebuzee Lebanon Bebuzee Lesotho Bebuzee Liberia Bebuzee Libya Bebuzee Liechtenstein Bebuzee Lithuania Bebuzee Luxembourg Bebuzee Madagascar Bebuzee Malawi Bebuzee Malaysia Bebuzee Maldives Bebuzee Mali Bebuzee Malta Bebuzee Marshall Islands Bebuzee Mauritania Bebuzee Mauritius Bebuzee Mexico Bebuzee Micronesia Bebuzee Moldova Bebuzee Monaco Bebuzee Mongolia Bebuzee Montenegro Bebuzee Morocco Bebuzee Mozambique Bebuzee Myanmar Bebuzee Namibia Bebuzee Nauru Bebuzee Nepal Bebuzee Netherlands Bebuzee New Zealand Bebuzee Nicaragua Bebuzee Niger Bebuzee Nigeria Bebuzee North Korea Bebuzee North Macedonia Bebuzee Norway Bebuzee Oman Bebuzee Pakistan Bebuzee Palau Bebuzee Panama Bebuzee Papua New Guinea Bebuzee Paraguay Bebuzee Peru Bebuzee Philippines Bebuzee Poland Bebuzee Portugal Bebuzee Qatar Bebuzee Republic of the Congo Bebuzee Romania Bebuzee Russia Bebuzee Rwanda Bebuzee Saint Kitts and Nevis Bebuzee Saint Lucia Bebuzee Saint Vincent and the Grenadines Bebuzee Samoa Bebuzee San Marino Bebuzee São Tomé and Príncipe Bebuzee Saudi Arabia Bebuzee Senegal Bebuzee Serbia Bebuzee Seychelles Bebuzee Sierra Leone Bebuzee Singapore Bebuzee Slovakia Bebuzee Slovenia Bebuzee Solomon Islands Bebuzee Somalia Bebuzee South Africa Bebuzee South Korea Bebuzee South Sudan Bebuzee Spain Bebuzee Sri Lanka Bebuzee Sudan Bebuzee Suriname Bebuzee Sweden Bebuzee Switzerland Bebuzee Syria Bebuzee Taiwan Bebuzee Tajikistan Bebuzee Tanzania Bebuzee Thailand Bebuzee Timor-Leste Bebuzee Togo Bebuzee Tonga Bebuzee Trinidad and Tobago Bebuzee Tunisia Bebuzee Turkey Bebuzee Turkmenistan Bebuzee Tuvalu Bebuzee Uganda Bebuzee Ukraine Bebuzee United Arab Emirates Bebuzee United Kingdom Bebuzee Uruguay Bebuzee Uzbekistan Bebuzee Vanuatu Bebuzee Venezuela Bebuzee Vietnam Bebuzee World Wide Bebuzee Yemen Bebuzee Zambia Bebuzee Zimbabwe
Blog Image

An Alzheimer's Drug Might Ease Hair-Pulling Disorder

A long-established Alzheimer’s drug can help people with a disorder that causes them to compulsively pull at their hair or pick at their skin, a new clinical trial has concluded.

Recommended Videos

Memantine considerably improved symptoms in 3 out of 5 patients with either trichotillomania (hair-pulling disorder) or excoriation (skin-picking) disorder, researchers reported in the American Journal of Psychiatry.

“I think it was encouraging that it helped reduce the behavior of picking and pulling, compared to a placebo,” said lead researcher Dr. Jon Grant, a professor of psychiatry and behavioral neuroscience at the University of Chicago. “It gives me the idea that perhaps we're onto the right underlying mechanism that might be happening here.”

Hair-pulling and skin-picking disorders affect an estimated 3% to 4% of Americans, Grant said. Patients obsessively pull out strands of hair or pick at their skin, often doing themselves real physical harm.

Memantine inhibits the activity of glutamate, one of the most abundant neurotransmitters in the brain.

Overly high levels of glutamate in the brain can cause nerve cells to become overexcited, and this has been associated with conditions like Alzheimer’s disease, Parkinson’s disease, Lou Gehrig’s disease and multiple sclerosis, according to the Cleveland Clinic.

Glutamate also has been linked to mental health problems like mood disorders and obsessive-compulsive disorder, the Cleveland Clinic says.

The U.S. Food and Drug Administration approved memantine to treat moderate-to-severe Alzheimer’s in 2003, and it is now available as a generic medication.

But some psychiatrists have been prescribing memantine off-label to help treat obsessive-compulsive disorder, “which is sort of a cousin of hair pulling and skin picking,” Grant said.

That gave Grant an idea.

“Could a medication that affects glutamate -- such as this fairly innocuous Alzheimer's medication, which is generic, cheap and has a fairly innocuous side effect profile -- could this be beneficial” in treating trichotillomania and excoriation disorder? he said.

To test this notion, Grant and his colleagues recruited 100 adults with skin-picking or hair-pulling disorder, and randomly assigned them to take either memantine or a placebo for eight weeks.

Memantine treatment wound up “much or very much” improving symptoms in 60% of patients taking the drug, while only 8% of patients on placebo reported similar improvement.

However, only about six patients in the memantine group (11%) completely stopped picking or pulling by the end of the trial, compared with one in the placebo group (2%). Read More

Previous Post

Study: Black People Visit ER for Mental Health at Highest Rates

Next Post

COVID-19 conjecture soars after latest report on origins

Comments